Ningjun Duan

机构：Universitätsmedizin Göttingen, Jiangsu Province Hospital, University of Göttingen, Nanjing Medical University · ORCID：0000-0001-6316-3796

发表论文 58 篇 · 总被引 259 次 · h-index 9

代表论文

Targeting PRMT5 inhibitor-induced adaptation in pancreatic cancer with the RBM39 degrader indisulam (2026 · Cancer Research Communications)
Additional file 8 of Targeting metabolic dependencies to reverse chemoradiotherapy resistance in colorectal cancer (2026 · Figshare)
Additional file 4 of Targeting metabolic dependencies to reverse chemoradiotherapy resistance in colorectal cancer (2026 · Figshare)
Reviewer #1 (Public review): Epigenetic and 3D Genome Changes Drive Primary Trastuzumab Resistance in HER2+ Breast Cancer (2026)
Additional file 2 of Targeting metabolic dependencies to reverse chemoradiotherapy resistance in colorectal cancer (2026 · Figshare)
Additional file 10 of Targeting metabolic dependencies to reverse chemoradiotherapy resistance in colorectal cancer (2026 · Figshare)